ANVS

NYSEStock

Annovis Bio, Inc.

$2.50+0.04 (+1.63%)

52-Week Range

$1.22

$5.10

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.31

Volume

202.7K

Avg Volume

330.0K

Performance

+3.80%

-34.92%

+3.80%

YTD

-32.60%

+27.46%

-85.05%

-92.61%

Price Chart

ETF Exposure

ANVS is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.00%	254,347	$687K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	29	$106	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,040	$4K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	5	$18	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	592,118	$1.6M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,114	$11K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	268	$981	$1.29B	0.17%

About ANVS ETF Exposure

Annovis Bio, Inc. (ANVS) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $2.50. Investors can gain exposure to ANVS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ANVS, sorted by portfolio weight.